Mechanistically, we identified nexilin (NEXN) as the direct target of CLK4 and the reduction of phosphorylated NEXN mediated the development of pathological myocardial hypertrophy and heart failure in Clk4-cKO mice. The gene discussed is CLK4; the disease is heart failure.